Skip to main navigation Skip to search Skip to main content

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

  • Annika Auranen
  • , Matthew A. Powell
  • , Vladyslav Sukhin
  • , Lisa M. Landrum
  • , Graziana Ronzino
  • , Joseph Buscema
  • , Dirk Bauerschlag
  • , Roy Lalisang
  • , David Bender
  • , Lucy Gilbert
  • , Amy Armstrong
  • , Tamar Safra
  • , Nicole Nevadunsky
  • , Alexandra Sebastianelli
  • , Brian Slomovitz
  • , Kari Ring
  • , Robert Coleman
  • , Iwona Podzielinski
  • , Ashley Stuckey
  • , Michael Teneriello
    • Sarah Gill, Bhavana Pothuri, Lyndsay Willmott, Sudarshan Sharma, Christine Dabrowski, Grace Antony, Shadi Stevens, Mansoor Raza Mirza, Evelyn Fleming

Research output: Contribution to journal › Article › peer-review

8   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology